Ying-Kai Wang

1.3k total citations
22 papers, 426 citations indexed

About

Ying-Kai Wang is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Ying-Kai Wang has authored 22 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Hepatology and 9 papers in Epidemiology. Recurrent topics in Ying-Kai Wang's work include Hepatitis C virus research (12 papers), HIV/AIDS drug development and treatment (10 papers) and Hepatitis B Virus Studies (7 papers). Ying-Kai Wang is often cited by papers focused on Hepatitis C virus research (12 papers), HIV/AIDS drug development and treatment (10 papers) and Hepatitis B Virus Studies (7 papers). Ying-Kai Wang collaborates with scholars based in United States, Germany and China. Ying-Kai Wang's co-authors include Elena Rustchenko, Rachel A. Baker, Masakazu Niimi, Richard D. Cannon, Frank Fischer, Fred Sherman, Karen Rigat, Susan B. Roberts, Auṣāf Aḥmad and M. Anaul Kabir and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

Ying-Kai Wang

22 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying-Kai Wang United States 12 226 186 134 111 71 22 426
Long V. Pham Denmark 13 309 1.4× 185 1.0× 141 1.1× 188 1.7× 29 0.4× 23 614
Shin-ichiro Hattori Japan 16 269 1.2× 114 0.6× 204 1.5× 44 0.4× 128 1.8× 36 715
Xue Zhou China 11 83 0.4× 305 1.6× 133 1.0× 250 2.3× 17 0.2× 14 513
Guangyi Wang China 14 254 1.1× 194 1.0× 226 1.7× 48 0.4× 134 1.9× 28 629
Keisuke Yusa Japan 16 300 1.3× 71 0.4× 283 2.1× 24 0.2× 101 1.4× 42 719
Inna L. Karpenko Russia 16 217 1.0× 194 1.0× 282 2.1× 49 0.4× 186 2.6× 43 607
Juliane Gentzsch Germany 12 51 0.2× 244 1.3× 119 0.9× 292 2.6× 21 0.3× 12 523
A Bertasso United States 14 143 0.6× 141 0.8× 115 0.9× 121 1.1× 36 0.5× 22 447
Xuzhao Zhang China 12 52 0.2× 102 0.5× 184 1.4× 38 0.3× 17 0.2× 34 478

Countries citing papers authored by Ying-Kai Wang

Since Specialization
Citations

This map shows the geographic impact of Ying-Kai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying-Kai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying-Kai Wang more than expected).

Fields of papers citing papers by Ying-Kai Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying-Kai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying-Kai Wang. The network helps show where Ying-Kai Wang may publish in the future.

Co-authorship network of co-authors of Ying-Kai Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ying-Kai Wang. A scholar is included among the top collaborators of Ying-Kai Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying-Kai Wang. Ying-Kai Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Yu, et al.. (2024). Non-Clinical Safety Evaluation of Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells in Cynomolgus Monkeys. International Journal of Nanomedicine. Volume 19. 4923–4939. 13 indexed citations
2.
Wang, Ying-Kai, Yunpeng Zhao, Mingzhu Ye, et al.. (2023). Chimeric CNS-targeting-peptide engineered exosomes for experimental autoimmune encephalomyelitis therapy. International Immunopharmacology. 124(Pt B). 110835–110835. 5 indexed citations
3.
Locke, Gregory, J.K. Muckelbauer, John S. Tokarski, et al.. (2022). Identification and characterization of TYK2 pseudokinase domain stabilizers that allosterically inhibit TYK2 signaling. Methods in enzymology on CD-ROM/Methods in enzymology. 667. 685–727. 3 indexed citations
4.
Hiebert, Sheldon, Jacques Friborg, Fei Yu, et al.. (2017). The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease. Bioorganic & Medicinal Chemistry Letters. 28(1). 43–48. 8 indexed citations
5.
Wang, Ying-Kai. (2017). Model for Evaluating the Logistics Service Quality of Cross-Border E-Commerce Enterprises with Intuitionistic Fuzzy Information. Journal of Computational and Theoretical Nanoscience. 14(2). 1136–1139. 8 indexed citations
6.
Sun, Li‐Qiang, Qian Zhao, Betsy J. Eggers, et al.. (2016). Functionalized triazines as potent HCV entry inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(4). 1089–1093. 3 indexed citations
7.
Nickel, Andrew, Brett R. Beno, S. Sheriff, et al.. (2016). Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 27(2). 295–298. 3 indexed citations
8.
Rigat, Karen, Hao Lu, Ying-Kai Wang, et al.. (2014). Mechanism of Inhibition for BMS-791325, a Novel Non-nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase. Journal of Biological Chemistry. 289(48). 33456–33468. 17 indexed citations
9.
Lemm, Julie A., Mengping Liu, Robert G. Gentles, et al.. (2014). Preclinical Characterization of BMS-791325, an Allosteric Inhibitor of Hepatitis C Virus NS5B Polymerase. Antimicrobial Agents and Chemotherapy. 58(6). 3485–3495. 47 indexed citations
10.
Ding, Min, Feng He, Thomas W. Hudyma, et al.. (2012). Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: Potent allosteric inhibitors of the hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 22(8). 2866–2871. 15 indexed citations
11.
Gentles, Robert G., Min Ding, Xiaofan Zheng, et al.. (2011). SAR studies on a series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides: Potent inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 21(10). 3142–3147. 5 indexed citations
12.
13.
Gentles, Robert G., S. Sheriff, Brett R. Beno, et al.. (2011). Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymerase. Bioorganic & Medicinal Chemistry Letters. 21(8). 2212–2215. 8 indexed citations
14.
Martin, Scott, Peter W. Glunz, Brett R. Beno, et al.. (2011). The Synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid Hepatitis C virus polymerase NS5B inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(10). 2869–2872. 11 indexed citations
15.
Wang, Ying-Kai, Karen Rigat, Jin-Hua Sun, Min Gao, & Susan B. Roberts. (2007). RNA template-mediated inhibition of hepatitis C virus RNA-dependent RNA polymerase activity. Archives of Biochemistry and Biophysics. 470(2). 146–152. 7 indexed citations
16.
Wang, Ying-Kai, Karen Rigat, Susan B. Roberts, & Min Gao. (2006). A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase. Analytical Biochemistry. 359(1). 106–111. 16 indexed citations
17.
Liu, Mengping, Matthew D. Healy, Brian Dougherty, et al.. (2006). Conserved Fungal Genes as Potential Targets for Broad-Spectrum Antifungal Drug Discovery. Eukaryotic Cell. 5(4). 638–649. 28 indexed citations
18.
Kabir, M. Anaul, Auṣāf Aḥmad, Jay Greenberg, Ying-Kai Wang, & Elena Rustchenko. (2005). Loss and gain of chromosome 5 controls growth of Candida albicans on sorbose due to dispersed redundant negative regulators. Proceedings of the National Academy of Sciences. 102(34). 12147–12152. 43 indexed citations
19.
Fischer, Frank, Masakazu Niimi, Rachel A. Baker, et al.. (1999). Specific Chromosome Alterations in Fluconazole-Resistant Mutants of Candida albicans. Journal of Bacteriology. 181(13). 4041–4049. 119 indexed citations
20.
Gao, Yan, Ying-Kai Wang, & Timothy R. Hoover. (1998). Mutational Analysis of the Phosphate-Binding Loop of Rhizobium meliloti DctD, a ς 54 -Dependent Activator. Journal of Bacteriology. 180(10). 2792–2795. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Long V. Pham Breakdown of academic impact, for papers by Shin-ichiro Hattori Breakdown of academic impact, for papers by Xue Zhou Breakdown of academic impact, for papers by Guangyi Wang Breakdown of academic impact, for papers by Keisuke Yusa Breakdown of academic impact, for papers by Inna L. Karpenko Breakdown of academic impact, for papers by Juliane Gentzsch Breakdown of academic impact, for papers by A Bertasso Breakdown of academic impact, for papers by Xuzhao Zhang
Rankless by CCL
2026